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Abstract
Whipple’s disease is a rare multisystemic infection caused by the bacterium Tropheryma whipplei. Endoscopic ﬁndings are
mostly limited and include pale yellow, shaggy mucosa with intermittent, superﬁcial, and erythematous eroded patches of
the duodenum. This video demonstrates the concept of advanced endoscopic imaging of Whipple’s disease using confocal
laser endomicroscopy. In this setting, endomicroscopy was able to visualize disease-speciﬁc histological changes in vivo. This
article is part of an expert video encyclopedia.
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Video Related to this Article
Techniques
High-deﬁnition white-light endoscopy and endomicroscopy.
Materials
• Endoscope: 90i Gastroscope and EG-3870CIK endomicro-
scope (Pentax, Hamburg, Germany).
• Video processor: EPK-i and EPK-1000 (Pentax, Hamburg,
Germany).
• Solution: Fluorescein sodium 10%, 5 ml.
Background and Endoscopic Procedure
Whipple’s disease represents a systemic infection caused by the
bacterium Tropheryma whipplei. The infection can affect various
organs, including the gastrointestinal, neurological, musculo-
skeletal, and cardiovascular systems. As clinical presentation
and laboratory ﬁndings are often nonspeciﬁc and reﬂect the
major organs involved, diagnosis of Whipple’s disease often
can be difﬁcult.1,2
Confocal laser endomicroscopy is an advanced endoscopic
imaging technique enabling real-time in vivo histology during
ongoing endoscopy at a magniﬁcation level of approximately
1000-fold. The technique enables visualization of cellular and
subcellular structures up to a penetration depth of 250 mm. To
obtain confocal imaging, it is necessary to use ﬂuorescence
agents, which can either be applied systemically (ﬂuorescein
sodium) or topically (acriﬂavine hydrochloride and cresyl
violet).3,4
In this video, endomicroscopy is used to visualize disease-
speciﬁc ﬁndings (foamy macrophages) of Whipple’s disease
in vivo during ongoing endoscopy.
Key Learning Points/Tips and Tricks
• Endomicroscopy enables in vivo microscopic imaging of
Whipple’s disease-associated histological changes (foamy
macrophages) during endoscopy.
• Apply mild suction to the mucosa while performing





00:04 This patient was referred to our endoscopy unit due to
general ill-health, with recurrent fever, malaise, and
diarrhea. Moreover, the patient reported recurrent
ankle pain over 1.5 years. Laboratory values
demonstrate signs of systemic inﬂammation and
normocytic anemia.
00:23 High-deﬁnition white-light endoscopy reveals pale
yellow shaggy mucosa with intermittent, superﬁcial,
erythematous eroded patches of the duodenum.
00:36 In order to obtain in vivo confocal imaging we now
inject 5 ml of 10% ﬂuorescein sodium intravenously.
Accordingly, the mucosa appears yellowish. The
embedded laser system is clearly visible at the
7 o’clock position. Note also the blue laser light,
which is scanning the duodenal mucosa.
01:01 In order to obtain high-quality confocal images in
focus, one has to gently push the confocal window
onto the duodenal mucosa and apply mild suction.
This article is part of an expert video encyclopedia. Click here for the full
Table of Contents.
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01:14 In vivo histology now clearly demarcates
morphological changes of the mucosa, such as
vessel and lymphatic calibre and anatomy of the
individual mucosal cells. Notable, endomicroscopy
reveals engorged but non-distorted vascular and
lymphatic vessels and massive macrophage
inﬁltration within the lamina propria.
Histopathology, afterwards, conﬁrmed in vivo
diagnosis of Whipple’s disease.
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